H
Heshan Kuruppu
Researcher at University of Sri Jayewardenepura
Publications - 20
Citations - 154
Heshan Kuruppu is an academic researcher from University of Sri Jayewardenepura. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 3, co-authored 10 publications receiving 30 citations.
Papers
More filters
Journal ArticleDOI
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.
Chandima Jeewandara,Achala Kamaladasa,Pradeep Darshana Pushpakumara,Deshni Jayathilaka,Inoka Sepali Aberathna,Danasekara Rallage Saubhagya Rasikangani Danasekara,Dinuka Guruge,Thushali Ranasinghe,Shashika Dayarathna,Thilagaraj Pathmanathan,Gayasha Somathilake,Panambara Arachchige Deshan Madhusanka,Shyrar Tanussiya Ramu,Tibutius T. P. Jayadas,Heshan Kuruppu,Ayesha Wijesinghe,Herath Mudiyanselage Thashmi Nimasha,Dushantha Milroy,Achini Anuja Nandasena,Poththawela Kankanam Gamage Nilanka Sanjeewani,Ruwan Wijayamuni,Sudath Samaraweera,Lisa Schimanski,Tiong Kit Tan,Tao Dong,Graham S. Ogg,Alain Townsend,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +28 more
TL;DR: In this paper, the authors assessed the immunogenicity of a single dose of the AZD1222 vaccine, at one month, in a cohort of health care workers (HCWs) (629 naive and 26 previously infected).
Posted ContentDOI
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naive and previously infected individuals in Sri Lanka
Chandima Jeewandara,Inoka Sepali Aberathna,Pradeep Pushpakumara,Achala Kamaladasa,Dinuka Guruge,Deshni Jayathilaka,Banuri Gunesekara,Shyrar Tanussiya,Heshan Kuruppu,Thushali Ranasinghe,Shashika Dayarathne,Osanda Dissanayaka,Nayanathara Gamalath,Dinithi Ekanayaka,Mpdj Jayamali,Ayesha Wijesinghe,Madushika Dissanayaka,Deshan Madushanka,Tibutius T. P. Jayadas,Anushika Mudunkotuwa,Gayasha Somathilaka,Michael Harvie,Thashmi Nimasha,Saubhagya Danasekara,Ruwan Wijayamuni,Lisa Schimanski,Tiong Kit Tan,Tao Dong,Alain Townsend,Graham S. Ogg,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +31 more
TL;DR: In this article, the authors investigated the immunogenicity of the vaccine, in individuals in Sri Lanka, and measured SARS-CoV-2-specific antibodies were measured in 282 individuals who were seronegative at baseline, and ACE2 receptor blocking antibodies, antibodies to the receptor binding domain (RBD) of the wild type (WT), B.1.7, B.351 and B.617.
Posted ContentDOI
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals.
Chandima Jeewandara,Inoka Sepali Aberathna,Pradeep Darshana Pushpakumara,Achala Kamaladasa,Dinuka Guruge,Ayesha Wijesinghe,Banuri Gunasekera,Shyrar Tanussiya,Heshan Kuruppu,Thushali Ranasinghe,Shashika Dayarathne,Osanda Dissanayake,Nayanathara Gamalath,Dinithi Ekanayake,Jeewantha Jayamali,Deshni Jayathilaka,Madushika Dissanayake,Tibutius T. P. Jayadas,Anushika Mudunkotuwa,Gayasha Somathilake,Michael Harvie,Thashmi Nimasha,Saubhagya Danasekara,Ruwan Wijayamuni,Lisa Schimanski,Pramila Rijal,Tiong Kit Tan,Tao Dong,Alain Townsend,Graham S. Ogg,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +31 more
TL;DR: In this article, the authors investigated immune responses in a cohort of Sri Lankan individuals after the second dose of the Sinopharm/BBIBP-CorV vaccine, 12 weeks after ELISA, by measuring SARS-CoV-2 specific total antibodies.
Journal ArticleDOI
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
Chandima Jeewandara,Inoka Sepali Aberathna,Pradeep Darshana Pushpakumara,Achala Kamaladasa,Dinuka Guruge,Ayesha Wijesinghe,Banuri Gunasekera,S. Ramu,Heshan Kuruppu,Thushali Ranasinghe,Shashika Dayarathna,O. Dissanayake,Nayanathara Gamalath,D Ekanayake,J. Jayamali,Deshni Jayathilaka,Madushika Dissanayake,Tibutius T. P. Jayadas,Anushika Mudunkotuwa,Gayasha Somathilake,M A. E. Harvie,Thashmi Nimasha,Saubhagya Danasekara,Ruwan Wijayamuni,Lisa Schimanski,Pramila Rijal,Tiong Kit Tan,Tao Dong,Alain Townsend,Graham S. Ogg,Gathsaurie Neelika Malavige +30 more
TL;DR: To determine the kinetics and persistence of immune responses following the Sinopharm/BBIBP‐CorV, immune responses in a cohort of Sri Lankan individuals are investigated.
Posted ContentDOI
Antibody and T-cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naive health care workers in Sri Lanka
Chandima Jeewandara,Achala Kamaladasa,Pradeep Pushpakumara,Deshni Jayathilaka,Inoka Sepali,Saubhagyagya Danasekara,Dinuka Guruge,Thushali Ranasinghe,Shashika Dayaratne,Thilagaraj T Padmanadan,Gayasha Somathilaka,Deshan Madusanka,Shyrar Tanussiya,Tibutius T. P. Jayadas,Heshan Kuruppu,Ayesha Wijesinghe,Nimasha Thashmi,Dushantha Milroy,Achini Anuja Nandasena,Nilanka Sanjeewani,Ruwan Wijayamuni,Sudath Samaraweera,Lisa Schimanski,Tiong Kit Tan,Tao Dong,Graham S. Ogg,Alain Townsend,Gathsaurie Neelika Malavige,Gathsaurie Neelika Malavige +28 more
TL;DR: In this article, a single dose of the AZD1222/Covishield vaccine was shown to be highly immunogenic in previously naive individuals inducing antibody levels greater than following natural infection.